Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Single-shot Adductor Canal Block in the outpatient clinic is safe, significantly decreased pain and analgesic consumption and may enhance the rehabilitation program
The ACB in the outpatient clinic is safe and can minimize postoperative pain. The primary goal of this research was to see how ACB affected the Visual Analog Score (VAS) pain score during the rehabilitation as opposed to controls. The secondary goal was to determine how much analgesic (etoricoxibe) was consumed on a daily basis.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| pain management post total knee arthroplasty with analgetic oral | Placebo Comparator | Patients in control group were given analgesic (etoricoxibe) on a daily basis, with the option to increase the dose if pain persisted, up to a maximum of 120 mg per day. |
|
| pain management post total knee arthroplasty with adductor canal block | Active Comparator | On postoperative day 14 (POD 14), the ACB was performed for ACB group |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| adductor canal block in outpatient clinic | Procedure | perform adductor canal block in outpatient clinic for patient post total knee arthroplasty |
|
| Measure | Description | Time Frame |
|---|---|---|
| Visual analog pain score (VAS) | A VAS scale was used to assess pain severity, with 0 indicating no pain and 10 indicating extreme pain | one month |
| Measure | Description | Time Frame |
|---|---|---|
| analgesic oral intake (etoricoxibe) | determine how much analgesic (etoricoxibe) was consumed on a daily basis. | one month |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| sholahuddin rhatomy, Dr | Contact | +6281808720707 | sholahuddin.rhatomy@ugm.ac.id |
| Name | Affiliation | Role |
|---|---|---|
| sholahuddin rhatomy, dr | Gadjah Mada University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Sholahuddin Rhatomy | Recruiting | Sleman | Special Region of Yogyakarta | 55281 | Indonesia |
Not provided
| ID | Term |
|---|---|
| D059787 | Acute Pain |
| ID | Term |
|---|---|
| D010146 | Pain |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D000554 | Ambulatory Care Facilities |
| D000700 | Analgesics |
| ID | Term |
|---|---|
| D006268 | Health Facilities |
| D005159 | Health Care Facilities Workforce and Services |
| D018689 | Sensory System Agents |
| D018373 | Peripheral Nervous System Agents |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Analgesics, etoricoxibe | Drug | anaelgetic oral intake |
|
|
| D045505 | Physiological Effects of Drugs |
| D020228 | Pharmacologic Actions |
| D020164 | Chemical Actions and Uses |
| D002491 | Central Nervous System Agents |
| D045506 | Therapeutic Uses |